Abiraterone Acetate Tablet, Film Coated
Product Images NDC 72162-2151

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Abiraterone Acetate (NDC 72162-2151). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Abiraterone Acetate Structural Formula (Image 02)

Chemical structure of abiraterone acetate shown as a molecular diagram with carbon rings, double bonds, and functional groups, including an acetate ester and a pyridine ring.*

FDA Label Image

Figure 1: Kaplan-meier Overall Survival Curves In Cou-aa-301 (intent-to-treat Analysis) (Image 03)

A survival curve chart showing percentage survival over time in months up to 21 months. The x-axis represents time to death in months, and the y-axis shows percentage survival from 0 to 100%. Two curves are compared: one for abiraterone acetate and one for placebo, with abiraterone acetate showing higher survival percentages across most of the timeline. The number of subjects at risk for each group is noted below the x-axis at various time points.*

FDA Label Image

Figure 2: Kaplan Meier Overall Survival Curves In Cou-aa-302 (Image 04)

A Kaplan-Meier survival curve chart depicting the percentage of subjects without death over time in months from randomization, comparing Abiraterone acetate and placebo groups. The vertical axis shows % subjects without death, and the horizontal axis shows months from randomization up to 60 months, with patient counts at specific time points shown below for both groups.*

FDA Label Image

Figure 3: Kaplan Meier Curves Of Radiographic Progression-free Survival In Cou-aa-302 (intent-to-treat Analysis) (Image 05)

Kaplan-Meier survival curve comparing the percentage of subjects without radiographic progression or death over time (months from randomization) between Abiraterone acetate and placebo groups. The graph includes number of subjects at risk at various time points below the x-axis.*

FDA Label Image

Figure 4: Kaplan-meier Plot Of Overall Survival; Intent-to-treat-population In Latitude Updated Analysis (Image 08)

A survival curve chart showing percent survival without death over months from randomization for two groups: Abiraterone acetate and Placebo. The x-axis represents months from randomization, ranging from 0 to 72, and the y-axis represents the percentage of subjects without death, from 0% to 100%. The chart includes a risk table below indicating the number of subjects at risk at various time points for each group.*

FDA Label Image

Label (Lbl721622151)

Label for Abiraterone Acetate Tablets, USP 500 mg film-coated tablets, packaged with 60 tablets. The label includes storage instructions (store at 20° to 25°C with permitted excursions), dispensing instructions, and safety warnings. It is relabeled by Bryant Ranch Prepack, Inc. and manufactured by Auro PR Inc. The product NDC is 72162-2151.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.